You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 14, April 13, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Crossroads: Conferences With Patients and Doctors
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Thyroid/ Parathyroid Diseases
 •Diagnosis
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Alert me on articles by topic

CLINICIAN’S CORNER
A 64-Year-Old Woman With Primary Hyperparathyroidism

Gordon J. Strewler, MD, Discussant

JAMA. 2005;293:1772-1779.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

DR BURNS: Ms Q is a 64-year-old woman with a history of mild hypercalcemia and hyperparathyroidism. She has managed care insurance.

Ms Q states that on a routine blood test 7 years ago she was noted to have a calcium level of 10.1 mg/dL (2.5 mmol/L). She has subsequently had her calcium checked on a biannual basis and it has ranged from 10.4 to 11.3 mg/dL (2.6-2.8 mmol/L). Ms Q was referred to an endocrinologist in December 2002 after her calcium was higher than 11 mg/dL (2.7 mmol/L) on 3 occasions. Her laboratory studies just prior to her visit revealed a calcium level of 11.1 mg/dL (2.8 mmol/L), a parathyroid hormone (PTH) level of 102 pg/mL, and a phosphate level of 3.4 mg/dL.

At the time of her visit, she reported a history of constipation since childhood with no recent . . . [Full Text of this Article]

MS Q: HER VIEW

AT THE CROSSROADS: QUESTIONS FOR DR STREWLER

Epidemiology and Pathophysiology

Evaluation

End-Organ Effects

Natural History and Pathogenesis

Medical Treatment Options

Surgical Treatment Options

Clinical Treatment Guidelines

RECOMMENDATIONS FOR MS Q

QUESTIONS AND COMMENT

AUTHOR INFORMATION

Author Affiliation: Dr Strewler is Professor and Vice-Chairman of Medicine, Beth Israel-Deaconess Medical Center, and Master, Walter Bradford Cannon Society, Harvard Medical School, Boston, Mass.


RELATED ARTICLE

Hyperparathyroidism
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2005;293(14):1818.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation and Treatment of Primary Hyperparathyroidism
Grey et al.
JAMA 2005;294:2699-2700.
FULL TEXT  

Evaluation and Treatment of Primary Hyperparathyroidism
Mikhail and Cope
JAMA 2005;294:2700-2700.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.